#cagrilintide 2024-11-08

for the archive amylin analogue, so its not a GLP-1 at all right

if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way, thats one data point
i keep the two on separate days so if something goes wrong i have a chance of knowing which

the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

lost 10lb over 12 months on the combination and i genuinely cannot apportion it, not advice obviously

quick one noticed something around week 2 on monotherapy, well after i had given up expecting to, thats one data point

cagrisema thats it

the fullness effect hasnt faded over 1 months, unlike my semaglutide appetite curve, for what its worth

back after 17 months, is monotherapy still a minority thing here

anyone dosing this on a different day to their cagrilintide

combination GI was worse than either alone for me, which is not what i had read anywhere

did anyone find monotherapy underwhelming

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

slower than the others

you cannot tell which of the two is doing what in a combination and i stopped pretending i could

is the weekly schedule the same here

whats REDEFINE testing exactly